Table 2

Baseline characteristics of 8954 white study participants by quintiles of mtDNA-CN, Atherosclerosis Risk in Communities study, 1987–1998

Mitochondrial DNA copy number quintiles
OverallQ1Q2Q3Q4Q5
N895417911791179017911791
mtDNA-CN0 (1.0)−1.44 (0.72)−0.44 (0.16)0.06 (0.13)0.53 (0.14)1.30 (0.45)
Age, years57.6 (5.9)57.7 (6.0)57.5 (6.0)57.6 (6.0)57.5 (5.9)57.6 (5.8)
Female53% (4766)54% (960)54% (968)52% (939)53% (958)52% (941)
Center
 Forsyth County, North Carolina30% (2733)31% (556)31% (549)30% (534)29% (525)32% (569)
 Jackson, Mississippi
 Minneapolis, Minnesota37% (3316)36% (644)37% (667)39% (706)39% (692)34% (607)
 Washington County, Maryland33% (2916)33% (593)32% (577)31% (553)32% (576)34% (617
Hypertension30% (2728)33% (597)31% (552)30% (536)29% (512)30% (531)
Cardiovascular disease9% (816)12% (217)9% (9160)9% (159)7% (131)8% (149)
Parental history of diabetes18% (1651)19% (336)19% (333)17% (307)17% (302)21% (373)
Diabetes10% (855)13% (237)10% (185)9% (165)7% (133)8% (135)
BMI, kg/m227 (5.0)28 (5.2)27 (5.0)28 (5.0)27 (4.9)28 (5.2)
High-risk waist-to-hip ratio
 Males (>0.90)91% (3839)93% (775)93% (767)90% (767)91% (760)90% (770)
 Females (>0.85)68% (3242)68% (652)66% (640)72% (672)65% (622)70% (656)
HDL-C, mg/dL
 Male42 (12.9)40 (12.2)42 (13.4)42 (12.1)43 (13.5)42.5 (13.2)
 Female56 (17.2)54 (17.2)56 (16.7)56 (17.4)57 (17.0)56 (17.8)
Total cholesterol, mg/dL210 (39.1)209 (41.2)209 (39.0)210 (37.6)209 (37.5)211 (39.9)
LDL-C, mg/dL132 (36.1)132 (37.3)131 (35.8)132 (35.1)132 (35.6)134 (36.7)
Triglycerides, mg/dL143 (94.7)140 (115.4)142 (90.2)142 (83.5)137 (86.1)142 (94.6)
Smoking status
 Never37% (3318)35% (636)39% (695)37% (655)37% (659)38% (673)
 Former41% (3674)39% (708)39% (696)42% (745)43% (770)42% (755)
 Current22% (1969)25% (449)22% (502)22% (392)20% (363)20% (363)
Alcohol drinker
 Never18% (1606)20% (363)18% (322)17% (310)16% (286)18% (325)
 Former18% (1650)20% (367)17% (305)20% (352)17% (296)18% (330)
 Current64% (5704)59% (1063)65% (1166)63% (1130)67% (1210)63% (1135)
Hemoglobin A1C, %5.6 (0.9)5.7 (1.1)5.6 (1.0)5.6 (0.8)5.5 (0.8)5.6 (0.8)
Hemoglobin A1C, mmol/mol38 (10.1)39 (12.3)38 (10.6)37 (9.1)37 (9.0)38 (9.1)
Lactate, mmol/L†8.5 (3.6)8.0 (2.6)8.3 (3.2)8.8 (3.3)8.2 (3.6)9.0 (4.7)
Fasting glucose, mg/dL*109 (34.4)114 (42.3)109 (35.0)108 (32.4)107 (30.5)108 (30.3)
HOMA-IR, U0.04 (0.07)0.04 (0.08)0.03 (0.03)0.03 (0.05)0.03 (0.03)0.06 (0.12)
hs-CRP, mg/L†3.9 (7.1)4.2 (6.4)3.6 (5.4)4.0 (8.2)3.5 (5.6)4.2 (8.9)
  • Mean (SD) or % (N). Hypertension defined as diastolic blood pressure ≥90 mm Hg or systolic blood pressure ≥140 mm Hg or use of any antihypertensive medication in the past 2 weeks. Cardiovascular disease defined as self-reported history of stroke or coronary heart disease (previous myocardial infarction, coronary heart disease or ECG confirmation of previous myocardial infarction). Diabetes defined as self-report of doctor diagnosis, use of glucose-lowering medication, fasting blood glucose ≥126 mg/dL or non-fasting blood glucose ≥200 mg/dL. To convert lipids from mg/dL to mmol/L, divide by 38.67 for total cholesterol, HDL-C and LDL-C, and by 88.57 for triglycerides.

  • *Glucose (mg/dL)/405, with insulin measured at visit 1.

  • †Lactate measured at visit 4, n=390 whites (357 without diabetes, 32 with diabetes); CRP measured at visit 2, n=6914 whites (6356 without diabetes, 554 with diabetes).

  • BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment-estimated insulin resistance (insulin (U/L); hs-CRP, high-sensitivity C reactive protein; LDL-C, low-density lipoprotein cholesterol; mtDNA-CN, mitochondrial DNA copy number.